4Front Ventures Announces Brokered Offering of Up to C$5,000,100 of Units

In This Article:

PHOENIX, Ariz., June 26, 2024 /CNW/ - 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" of the "Company"), a vertically integrated, multi-state cannabis operator and retailer, is pleased to announce that it has entered into an agreement with Eight Capital  (the "Lead Agent"), as lead agent and sole bookrunner, on behalf of a syndicate of agents to be formed (collectively with the Lead Agent, the "Agents") to act as agents on a "best efforts" basis to sell up to 47,620,000 units of the Company (the "Units") at a price of C$0.105 per Unit (the "Offering Price") for gross proceeds of up to C$5,000,100 (the "Offering").

(CNW Group/4Front Ventures Corp.)

Each Unit will consist of one class A subordinate voting share in the capital of the Company (a "SVS") and one SVS purchase warrant (each whole warrant, a "Warrant"). Each Warrant will entitle the holder thereof to purchase one additional SVS (a "Warrant Share") for a period of 60 months following the closing of the Offering at an exercise price of C$0.13 per Warrant Share. Subject to the listing requirements of the Canadian Securities Exchange (the "CSE"), it is the intention of the Company to have the Warrants listed on the CSE upon closing of the Offering.

The Company has granted the Agents an option to ?offer for sale up to an additional 15% of the Units, at the Offering Price, ?exercisable in ?whole or in part at any time for a period of up to 48 hours ?prior to the closing date of the offering (the "Agents' Option").?

The Units are being offered and sold in this Offering pursuant to the Company's shelf registration statement on Form S-3 (No. 333-276069) declared effective by the U.S. Securities and Exchange Commission (the "SEC") on May 8, 2024 and accompanying prospectus of the same date, as further supplemented by the preliminary prospectus supplement, dated June 26, 2024? (collectively, the "?U.S. Prospectus"), and pursuant to the listed issuer financing exemption from Canadian prospectus requirements under Part 5A of National Instrument 45-106 – Prospectus Exemptions (the "Listed Issuer Financing Exemption").

The Units offered under the Listed ?Issuer Financing Exemption will not be subject to resale restrictions pursuant to applicable Canadian ?securities laws. There is an offering document that can be accessed under the ?Company's profile at www.sedarplus.ca and on the Company's website at - https://4frontventures.com/life-offering/. ?Prospective investors should read this offering document before making an investment decision.?